RFID in Clinical Trials

Abstract

Estimates for the true cost of drug manufacturing, from drug discovery to commercialization, range from hundreds of millions to billions of dollars. Irrespective of the financial considerations, finding a cure and improving the quality of life for those suffering from disease has immeasurable value. This report shows that reducing the cost of developing drugs, from discovery to the marketplace, translates into a win for everyone in the Life Sciences supply chain.

Report

This report requires a Premium Subscription (available at no cost).
To download this report, please log in or register.


Monitoring the complex and lengthy business processes, as well as capturing and disseminating critical data and information in a highly regulated industry are critical to the success of this industry.

This report, the third in the series related to the use of advanced technology enablers in the Life Sciences Industry, explores using technology to streamline the entire business process. In particular, this report evaluates the use of wireless networks, coupled with auto-identification technologies – sensors, RFID, and bar-codes – to identify both current levels of adoption as well as future areas of opportunity.

In addition, this report identifies some of the key constraints, as well as potential process improvements that could be supported by technology, enabling the industry to streamline the discovery, clinical trials, and commercialization processes – reducing both time to market and, optimistically, time to cure!


This report requires a Premium Subscription (available at no cost).
To download this report, please log in or register.

Scroll to Top